Hyam Levitsky

Hyam Levitsky

Chief Tech/Sci/R&D Officer chez CENTURY THERAPEUTICS, INC.

Fortune : 2 M $ au 29/02/2024

66 ans
Health Technology
Commercial Services
Consumer Services

Profil

Hyam I.
Levitsky
holds the position of President-Research & Development at Century Therapeutics, Inc. Dr. Levitsky is also on the board of Replimune Group, Inc. and Prokarium Ltd.
and Member-Cancer Immunotherapy Consortium at Cancer Research Institute, Member of American Association for Cancer Research and Member of American Society of Hematology.
In his past career Dr. Levitsky was President-Research & Development at Century Therapeutics, Inc. and President-Research & Development at Century Therapeutics, Inc. (a subsidiary of Century Therapeutics, Inc.), Head-Cancer Immunology Experimental Medicine at Roche Holding AG Head-Cancer Immunotherapy Experimental Medicine at F.
Hoffmann-La Roche Ltd.
and Head-Cancer Immunology at Roche Pharmaceuticals, Inc. (both are subsidiaries of Roche Holding AG), Member of American Society for Clinical Investigation, Chief Scientific Officer & Executive VP at Juno Therapeutics, Inc., Scientific Director at The Johns Hopkins University, Professor at The Sidney Kimmel Comprehensive Cancer Center and Professor at The Johns Hopkins University School of Medicine.
He received an undergraduate degree from School of Engineering & Applied Science and a doctorate from The Johns Hopkins University School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
07/03/2024 560 544 ( 0,94% ) 2 M $ 29/02/2024
30/06/2023 0 ( -.--% ) - $ 29/02/2024

Postes actifs de Hyam Levitsky

SociétésPosteDébut
REPLIMUNE GROUP, INC. Director/Board Member 01/05/2018
CENTURY THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 11/04/2023
Director/Board Member 01/10/2020
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Tous les postes actifs de Hyam Levitsky

Anciens postes connus de Hyam Levitsky

SociétésPosteFin
CENTURY THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 01/01/2023
JUNO THERAPEUTICS INC Chief Tech/Sci/R&D Officer 01/04/2018
ROCHE HOLDING AG Corporate Officer/Principal 01/02/2015
░░ ░░░░░░░░░░░ ░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Hyam Levitsky

Formation de Hyam Levitsky

The Johns Hopkins University School of Medicine Doctorate Degree
School of Engineering & Applied Science Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Hyam Levitsky

Relations

100 +

Relations au 1er degré

18

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
ROCHE HOLDING AG

Health Technology

AGENUS INC.

Health Technology

REPLIMUNE GROUP, INC.

Health Technology

CARISMA THERAPEUTICS, INC.

Health Technology

Entreprise privées11

Health Technology

Commercial Services

Health Services

Commercial Services

Commercial Services

Health Technology

Health Services

Health Technology

Commercial Services

Century Therapeutics, Inc.

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Hyam Levitsky